Related references
Note: Only part of the references are listed.Consensus of experts from the French Society of Geriatrics and Gerontology on the management of heart failure in very old subjects
Olivier Hanon et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2021)
Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry
Masami Nishino et al.
ESC HEART FAILURE (2021)
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
Pablo Alejandro Paz et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Cardio-geriatric model of care in acute heart failure: initial experience of a multidisciplinary approach in complex elderly patients
Andrew Mulligan et al.
INTERNAL MEDICINE JOURNAL (2020)
Evaluation and management of heart failure with preserved ejection fraction
Barry A. Borlaug
NATURE REVIEWS CARDIOLOGY (2020)
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure
Charles Faselis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
National survey on the management of heart failure in individuals over 80years of age in French geriatric care units
Clemente Boully et al.
BMC GERIATRICS (2019)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske et al.
EUROPEAN HEART JOURNAL (2019)
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86000 Individuals
Nathalie Conrad et al.
JAMA CARDIOLOGY (2019)
Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure
Cristiana Vitale et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction A Secondary Analysis of the TOPCAT Trial
Daniel N. Silverman et al.
JAMA NETWORK OPEN (2019)
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Apostolos Tsimploulis et al.
JAMA CARDIOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Potentially inappropriate use of furosemide in a very elderly population: An observational study
Carla Rodriguez-Cillero et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Epidemiology of heart failure with preserved ejection fraction
Shannon M. Dunlay et al.
NATURE REVIEWS CARDIOLOGY (2017)
Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
Sang Eun Lee et al.
JACC-HEART FAILURE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Predictors for hospitalizations in elderly patients with clinical symptoms of heart failure: A 10-year observational primary healthcare study
Mona Olofsson et al.
JOURNAL OF CLINICAL GERONTOLOGY & GERIATRICS (2016)
Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents The PARTAGE Study
Athanase Benetos et al.
JAMA INTERNAL MEDICINE (2015)
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Sanjiv J. Shah et al.
CIRCULATION (2015)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer et al.
CIRCULATION (2015)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Assessment of Left Ventricular Function in Older Medicare Beneficiaries With Newly Diagnosed Heart Failure
Lesley H. Curtis et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Low Systolic Blood Pressure at Admission Predicts Long-Term Mortality in Heart Failure With Preserved Ejection Fraction
Otilia Buiciuc et al.
JOURNAL OF CARDIAC FAILURE (2011)
Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)
Ravi V. Desai et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Low blood pressure in the very old, a consequence of imminent heart failure: the Leiden 85-plus Study
T. van Bemmel et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)
Dirk J. van Veldhuisen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary Digitalis Investigation Group trial
Ali Ahmed et al.
CIRCULATION (2006)
Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure
A Ahmed
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
S Yusuf et al.
LANCET (2003)